• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Comparative observation on therapeutic effect of chronic persistent bronchial asthma treated with heat-sensitive moxibustion and medication].

作者信息

Liang Chao, Zhang Tang-Fa, Yang Kun

机构信息

College of Acupuncture and Orthopaedics, Hubei University of CM, Wuhan, China.

出版信息

Zhongguo Zhen Jiu. 2010 Nov;30(11):886-90.

PMID:21246841
Abstract

OBJECTIVE

To probe a better therapy for chronic persistent asthma.

METHODS

Thirty-six cases of chronic persistent asthma were randomly divided into a beat-sensitive moxibustion group (17 cases) and a western medication group (19 cases). In heat-sensitive moxibustion group, the sensitization points between Feishu (BL 13) and Geshu (BL 17) were selected with heat-sensitive moxibustion; in western medication group, Seretide inhalant was applied. The patients of both groups were continuously treated for 3 months and the therapeutic effects were evaluated by clinical symptom scores and pulmonary ventilation function test.

RESULTS

After treatment, the effective rate of 88.2% (15/17) in heat-sensitive moxibustion group was superior to that of 47.4% (9/19) in western medication group (P < 0.05); the clinical symptom scores and pulmonary ventilation function were obviously improved in the two groups, and the heat-sensitive moxibustion group was superior to the western medication group (all P < 0.05).

CONCLUSION

For chronic persistent bronchial asthma, heat-sensitive moxibustion can improve the clinical symptoms and the pulmonary ventilation function, and it is better than Seretide inhalant.

摘要

相似文献

1
[Comparative observation on therapeutic effect of chronic persistent bronchial asthma treated with heat-sensitive moxibustion and medication].
Zhongguo Zhen Jiu. 2010 Nov;30(11):886-90.
2
[Comparative study on effect of acupoint heat-sensitive moxibustion and Seretide on the symptoms of bronchial asthma at chronic persistent stage].穴位热敏灸与沙美特罗替卡松对支气管哮喘慢性持续期症状影响的对比研究
Zhongguo Zhen Jiu. 2012 Jul;32(7):593-6.
3
[Impact of acupoint heat-sensitive moxibustion on lung function and life quality of patients with chronic persistent bronchial asthma: a randomized controlled study].[穴位热敏灸对慢性持续性支气管哮喘患者肺功能及生活质量的影响:一项随机对照研究]
Zhongguo Zhen Jiu. 2011 Nov;31(11):965-70.
4
Comparison of heat-sensitive moxibustion versus fluticasone/salmeterol (seretide) combination in the treatment of chronic persistent asthma: design of a multicenter randomized controlled trial.热敏灸与沙美特罗/氟替卡松(舒利迭)治疗慢性持续哮喘的疗效比较:一项多中心随机对照试验的设计。
Trials. 2010 Dec 15;11:121. doi: 10.1186/1745-6215-11-121.
5
[Observation on the effects of the treatment of sillicosis merger asthma].矽肺合并哮喘治疗效果观察
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2013 May;31(5):386-8.
6
Curative effect of heat-sensitive moxibustion on chronic persistent asthma: a multicenter randomized controlled trial.热敏灸治疗慢性持续期哮喘的疗效:一项多中心随机对照试验。
J Tradit Chin Med. 2013 Oct;33(5):584-91. doi: 10.1016/s0254-6272(14)60025-x.
7
Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.丙酸氟替卡松/沙美特罗通过氢氟烷烃134a定量吸入器每日两次给药在青少年和成年持续性哮喘患者中的疗效和耐受性:一项随机、双盲、安慰剂对照的12周研究。
Clin Ther. 2006 Jan;28(1):73-85. doi: 10.1016/j.clinthera.2006.01.008.
8
Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone.经都保吸入丙酸氟替卡松/沙美特罗长期治疗可改善哮喘控制,优于单用丙酸氟替卡松。
Allergy Asthma Proc. 2011 Mar-Apr;32(2):127-36. doi: 10.2500/aap.2011.32.3426. Epub 2010 Dec 28.
9
Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.沙美特罗加丙酸氟替卡松与丙酸氟替卡松加孟鲁司特的比较:一项关于对哮喘气道炎症影响的随机对照试验
Respir Res. 2007 Sep 27;8(1):67. doi: 10.1186/1465-9921-8-67.
10
Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).使用沙美特罗/丙酸氟替卡松(50/250微克)联合制剂(SAS 40023)对有症状的轻至中度支气管哮喘进行初始治疗。
Eur J Med Res. 2002 Jan 29;7(1):1-7.

引用本文的文献

1
A network meta-analysis of different acupuncture modalities in the treatment of bronchial asthma.不同针刺方式治疗支气管哮喘的网状Meta 分析。
BMC Pulm Med. 2023 Sep 22;23(1):357. doi: 10.1186/s12890-023-02645-8.